Intrua Financial’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
CIM
ATO
CGH
Intrua Financial's GILD Position: Q2 2026 in Review
Intrua Financial reduced its Gilead Sciences (GILD) stake by 1.5% in Q2 2026, selling an estimated $5.93K and leaving 2,910 shares worth $368K. The position accounts for 0.03% of the portfolio, ranked #351.
Intrua Financial first reported a position in GILD in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.92M in Q4 2021. 836 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Intrua Financial held 2,910 shares of Gilead Sciences worth $368K as of Q2 2026.
- Intrua Financial sold 45 Gilead Sciences shares in Q2 2026, an estimated $5.93K.
- Gilead Sciences made up 0.03% of Intrua Financial's portfolio in Q2 2026, its #351 holding.
- Intrua Financial first reported a position in Gilead Sciences in Q2 2020 and has held it in 25 quarters since.
- Intrua Financial's Gilead Sciences position peaked at $1.92M in Q4 2021.
- 836 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Intrua Financial's 13F filing for Q2 2026, filed 24 Jul 2026.